The company was notified on (b)(6) 2015 about an issue related to a carbomedics standard mitral valve (model m7-029, (b)(4)).On (b)(6) 2015, the d.M.V.(b)(6) patient, implanted a valve.On (b)(6) 2015 the patient returned to the hospital to re-operate the valve due thrombosis on the valve.The patient was re-operated to remove the prosthesis and replacement with another.
|
The review of device history records confirmed that the prosthesis sn (b)(4) satisfied all material, visual, and performance standards required for a m7-029 (b)(4) standard mitral valve at the time of manufacture and release.The visual inspections performed on the returned valve confirmed the absence of manufacturing defects.No information about the patient's risk factors and the post-operative inr patient's regimen were provided from the hospital.In the present case, no explanation for the reported event can be given on the basis of the lack of information received from the field.
|